Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling

Systemic Sclerosis (SSc) is a disease with limited therapeutic possibilities. Mesenchymal stem cells (MSCs)-therapy could be a promising therapeutic option, however the ideal MSCs source has not yet been found. To address this problem, we perform comparison between bone marrow (BM)-MSCs and adipose...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Sci Rep
Главные авторы: Di Benedetto, Paola, Panzera, Noemi, Cipriani, Paola, Mastroiaco, Valentina, Tessitore, Alessandra, Liakouli, Vasiliki, Ruscitti, Piero, Berardicurti, Onorina, Carubbi, Francesco, Guggino, Giuliana, Bianchi, Andrea, Di Marco, Antinisca, Ciccia, Francesco, Alesse, Edoardo, Giacomelli, Roberto
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group UK 2019
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6509164/
https://ncbi.nlm.nih.gov/pubmed/31073190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-43638-0
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы